Literature DB >> 7585562

Differential cellular expression of the human MSH2 repair enzyme in small and large intestine.

T M Wilson1, A Ewel, J R Duguid, J N Eble, M K Lescoe, R Fishel, M R Kelley.   

Abstract

The human MSH2 (hMSH2) protein is responsible for the initial recognition of mismatched nucleotides during the postreplication mismatch repair process. Loss of hMSH2 function has been demonstrated to lead to the accumulation of replication errors, resulting in a mutator phenotype, which may be responsible for the multiple mutations required for multi-stage carcinogenesis. Alterations of the hMSH2 gene has been linked to approximately 60% of hereditary nonpolyposis colon cancer cases. Colon tumors in hereditary nonpolyposis colon cancer patients originate within benign preneoplastic adenomas and display replication errors in the form of microsatellite instability. The aim of this study was to investigate the cellular expression of the hMSH2 protein in cells of the large and small intestines. Using antibody specific for hMSH2, we have determined that this protein is highly expressed in cells of the crypts of Lieberkühn that are undergoing rapid renewal in both the ileum and colon. Proliferative perifibroblasts in the colon also showed significant presence of the hMSH2 protein. These results confirm the hypothesis that hMSH2 is expressed in highly proliferative cells of the gut, and mutations in this gene could, therefore, be expected to expedite the progression of adenoma to carcinoma in this tissue.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585562

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Genomic Instability Promoted by Overexpression of Mismatch Repair Factors in Yeast: A Model for Understanding Cancer Progression.

Authors:  Ujani Chakraborty; Timothy A Dinh; Eric Alani
Journal:  Genetics       Date:  2018-04-13       Impact factor: 4.562

2.  Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues.

Authors:  H Ye; T F Kelly; U Samadani; L Lim; S Rubio; D G Overdier; K A Roebuck; R H Costa
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

3.  Fusion tyrosine kinase NPM-ALK Deregulates MSH2 and suppresses DNA mismatch repair function novel insights into a potent oncoprotein.

Authors:  Leah C Young; Kathleen M Bone; Peng Wang; Fang Wu; Benjamin A Adam; Samar Hegazy; Pascal Gelebart; Jelena Holovati; Liang Li; Susan E Andrew; Raymond Lai
Journal:  Am J Pathol       Date:  2011-05-24       Impact factor: 4.307

4.  hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6.

Authors:  S Acharya; T Wilson; S Gradia; M F Kane; S Guerrette; G T Marsischky; R Kolodner; R Fishel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

5.  Long-lived keratin 15+ esophageal progenitor cells contribute to homeostasis and regeneration.

Authors:  Véronique Giroux; Ashley A Lento; Mirazul Islam; Jason R Pitarresi; Akriti Kharbanda; Kathryn E Hamilton; Kelly A Whelan; Apple Long; Ben Rhoades; Qiaosi Tang; Hiroshi Nakagawa; Christopher J Lengner; Adam J Bass; E Paul Wileyto; Andres J Klein-Szanto; Timothy C Wang; Anil K Rustgi
Journal:  J Clin Invest       Date:  2017-05-08       Impact factor: 14.808

6.  Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis.

Authors:  M P de Leon; M Pedroni; P Benatti; A Percesepe; C Di Gregorio; M Foroni; G Rossi; M Genuardi; G Neri; F Leonardi; A Viel; E Capozzi; M Boiocchi; L Roncucci
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

Review 7.  Cervical neuroendocrine tumor in a young female with Lynch Syndrome.

Authors:  Ibraheem Yousef; Fadi Siyam; Lester Layfield; Carl Freter; James R Sowers
Journal:  Neuro Endocrinol Lett       Date:  2014       Impact factor: 0.765

8.  Evidence that hMLH3 functions primarily in meiosis and in hMSH2-hMSH3 mismatch repair.

Authors:  Nicole Charbonneau; Ravindra Amunugama; Christoph Schmutte; Kristine Yoder; Richard Fishel
Journal:  Cancer Biol Ther       Date:  2009-07-30       Impact factor: 4.742

9.  Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry.

Authors:  Jinru Shia
Journal:  J Mol Diagn       Date:  2008-06-13       Impact factor: 5.568

Review 10.  The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer.

Authors:  Janindra Warusavitarne; Margaret Schnitzler
Journal:  Int J Colorectal Dis       Date:  2006-11-16       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.